V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10384939 | 10040607 | 1.52 | 0 | 03 | 2017-10-12 | 2017-11-01 | FEC 60 or 75 | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100235927 |
| 10384976 | 10040609 | 1.71 | 60 | 03 | 2017-12-11 | 2017-12-31 | null | 02 | N | VENETOCLAX | 101368105 |
| 10385064 | 10040610 | 1.72 | 79 | Adjuvant (A) | 2018-03-04 | 2018-03-05 | Folfirinox | Y | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100407170 |
| 10385073 | 10040611 | 1.75 | 71.3 | null | 2018-08-25 | 2018-08-26 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | null | CISPLATIN + FLUOROURACIL | 100805487 |
| 10385116 | 10040612 | 1.49 | 89.9 | Curative (C) | 2020-06-10 | 2020-06-11 | Avelumab | null | null | AVELUMAB | 101000241 |
| 10385171 | 10040615 | 1.7 | 104 | null | 2020-03-27 | 2020-04-21 | Palbociclib | 02 | null | PALBOCICLIB | 100428771 |
| 10385357 | 10040616 | 1.69 | 70.9 | Neo-adjuvant (N) | 2019-12-23 | 2020-01-06 | R Chlorambucil | 02 | N | CHLORAMBUCIL + RITUXIMAB | 101587188 |
| 10385437 | 10040617 | 1.76 | 60.2 | Palliative (P) | 2017-12-03 | 2017-12-03 | CHLORAMBUCIL + RITUXIMAB | 02 | N | CHLORAMBUCIL + RITUXIMAB | 101142260 |
| 10385445 | 10040618 | 1.64 | 60.1 | Palliative (P) | 2019-10-21 | 2019-10-27 | Capecitabine + Cisplatin | 02 | Y | CVP R | 100667234 |
| 10385483 | 10040619 | null | null | null | 2019-07-15 | 2019-07-15 | Mitomycin Intravesical | 02 | null | MITOMYCIN INTRAVESICULAR | 100386453 |
| 10385524 | 10040622 | 1.73 | 75.6 | Palliative (P) | null | 2019-12-15 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100116411 |
| 10385700 | 10040626 | 1.75 | 66 | 02 | 2019-12-09 | 2019-12-09 | Temozolomide + RT | N | N | TEMOZOLOMIDE | 100124088 |
| 10385729 | 10040627 | 1.86 | 78.5 | Palliative (P) | 2019-07-31 | 2019-08-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101066777 |
| 10385774 | 10040629 | 0 | 64.7 | Palliative (P) | 2021-03-02 | 2021-03-02 | FEC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101162058 |
| 10385898 | 10040631 | 1.57 | null | 03 | 2016-06-11 | 2016-06-14 | Gemcitabine + Capecitabine | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101113605 |
| 10385978 | 10040632 | 1.56 | 90 | null | 2021-10-24 | 2021-10-25 | FLUOROURACIL | 02 | null | FLUOROURACIL | 100721505 |
| 10386123 | 10040634 | 1.65 | null | Disease modification (D) | 2017-06-12 | 2017-11-26 | Irinotecan + Modified De Gramont | null | N | FLUOROURACIL + IRINOTECAN | 101063711 |
| 10386166 | 10040635 | 1.66 | 70.6 | 03 | 2016-09-13 | 2016-10-02 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | null | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 101572943 |
| 10386169 | 10040636 | 1.56 | 0 | Adjuvant (A) | 2018-08-20 | 2018-09-11 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101573464 |
| 10386170 | 10040637 | 1.6 | 90.1 | Neo-adjuvant (N) | 2018-12-18 | 2018-12-21 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100554719 |
| 10386182 | 10040638 | 1.77 | 71.7 | null | 2019-05-02 | 2019-05-05 | Venetoclax | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB | 100588810 |
| 10386199 | 10040639 | 0 | 0 | Neo-adjuvant (N) | 2017-11-08 | 2017-11-11 | Cisplatin + Vinorelbine (IV) | 02 | N | DABRAFENIB + TRAMETINIB | 101126221 |
| 10386259 | 10040640 | 1.6 | 73.8 | Palliative (P) | 2019-11-07 | 2019-11-14 | null | 02 | N | BUSULFAN | 100045841 |
| 10386265 | 10040641 | 1.71 | 79 | Disease modification (D) | null | 2019-11-29 | null | 02 | null | DABRAFENIB + TRAMETINIB | 101452827 |
| 10386376 | 10040643 | 1.85 | 64.7 | 03 | 2020-07-04 | 2020-07-14 | Cyclophosphamide + Docetaxel | null | N | VENETOCLAX | 100764307 |
| 10386379 | 10040644 | 1.61 | 62.8 | Curative (C) | 2019-07-15 | 2019-07-23 | Sunitinib | null | null | MITOMYCIN | 100625602 |
| 10386424 | 10040645 | 1.78 | 0 | 03 | 2016-09-04 | 2016-09-11 | CVP R | 02 | N | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 100487604 |
| 10386476 | 10040647 | 1.67 | 53.9 | Palliative (P) | 2020-06-02 | 2020-06-03 | Bortezomib +/- Dexamethasone | 02 | null | BORTEZOMIB | 101787548 |
| 10386484 | 10040648 | 1.83 | 98.4 | null | 2018-02-12 | 2018-02-22 | CVP R | 02 | null | DARATUMUMAB | 101376004 |
| 10386489 | 10040649 | 1.8 | 86.9 | null | 2022-05-16 | 2022-05-30 | TEMOZOLOMIDE | null | null | TEMOZOLOMIDE | 100133045 |
| 10386533 | 10040650 | 0 | 85 | Palliative (P) | 2017-01-15 | 2017-01-15 | CYTARABINE | 02 | N | VENETOCLAX | 101320008 |
| 10386551 | 10040651 | 1.6 | 86 | Palliative (P) | 2015-11-13 | 2015-11-13 | FLUOROURACIL + IRINOTECAN | 02 | N | FLUOROURACIL + IRINOTECAN | 101836504 |
| 10386610 | 10040653 | 1.56 | 0 | Palliative (P) | 2020-06-06 | 2020-07-17 | Mitomycin Intravesical | null | N | MITOMYCIN INTRAVESICULAR | 100804404 |
| 10386622 | 10040654 | 1.57 | 49 | Disease modification (D) | null | 2018-05-21 | CTD Attenuated (Thalidomide 50mg) | 02 | N | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 101711686 |
| 10386670 | 10040656 | 1.71 | 98.4 | Adjuvant (A) | 2019-04-15 | 2019-04-15 | DABRAFENIB + TRAMETINIB | 02 | N | DARATUMUMAB | 101070837 |
| 10386712 | 10040658 | 1.55 | 86.4 | Curative (C) | null | 2021-12-10 | Avelumab | null | N | AVELUMAB | 100626141 |
| 10386908 | 10040660 | 1.71 | 89.1 | null | 2019-11-22 | 2019-11-30 | Acalabrutinib | 02 | null | ACALABRUTINIB | 101486737 |
| 10386943 | 10040661 | 0 | 137 | Palliative (P) | null | 2020-07-23 | Folfirinox | 02 | null | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 101260708 |
| 10386954 | 10040662 | 1.58 | 69.8 | Curative (C) | 2022-02-10 | 2022-02-12 | EOX | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100461161 |
| 10387006 | 10040664 | 1.56 | 67.4 | 03 | 2016-08-10 | 2016-08-15 | Venetoclax | 02 | N | DARATUMUMAB | 101809402 |
| 10387021 | 10040665 | 1.8 | 70.6 | Palliative (P) | null | 2018-03-24 | Avelumab | null | N | AVELUMAB | 100778654 |
| 10387172 | 10040668 | 1.65 | 0 | Palliative (P) | 2018-08-08 | 2018-08-08 | CHLORAMBUCIL + RITUXIMAB | 02 | N | CHLORAMBUCIL + RITUXIMAB | 101149574 |
| 10387213 | 10040669 | 0 | 77.3 | null | 2019-10-24 | 2019-11-05 | Cisplatin + Vinorelbine (IV) | null | null | POMALIDOMIDE | 100444504 |
| 10387287 | 10040670 | 1.6 | 87 | Adjuvant (A) | 2019-09-09 | 2019-09-09 | Capecitabine + Cisplatin | N | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100832387 |
| 10387455 | 10040675 | 1.75 | 71 | null | 2020-06-23 | 2020-06-24 | Sunitinib | 02 | N | CLADRIBINE | 100642170 |
| 10387479 | 10040676 | 1.7 | 137 | null | 2017-01-09 | 2017-01-27 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | null | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 101363517 |
| 10387513 | 10040677 | 1.71 | 63.9 | Palliative (P) | 2019-01-03 | 2019-01-14 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100681597 |
| 10387611 | 10040679 | 1.68 | 87.6 | Palliative (P) | 2018-01-15 | 2018-01-27 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100167365 |
| 10387650 | 10040680 | 1.79 | 0 | Adjuvant (A) | 2017-11-25 | 2017-11-25 | DABRAFENIB + TRAMETINIB | 02 | N | CISPLATIN + VINORELBINE | 100531226 |
| 10387764 | 10040682 | null | 72.15 | null | null | 2020-02-04 | FLUOROURACIL + IRINOTECAN | 02 | null | FLUOROURACIL + IRINOTECAN | 101442754 |